Moderate pharmaceutical price increases announced in Hungary

20 March 2006

The prices of 42 non-reimbursed pharmaceuticals were increased in Hungary on March 1. Mainly painkillers, anti-allergy drugs, sleeping pills and antidepressants were affected with a moderate price hike of 20-30 forint ($0.09-$0.14) on average. As a result of the Pharmaceutical Market Regulation Act (October 2005), manufacturers are free to increase the price of non-reimbursed pharmaceuticals monthly instead of the previous practice of quarterly announcement through the Hungarian Pharmacy Guild.

In first-quarter of 2006, the price of 31 antihypertensives was reduced due to their increased subsidy and further such reductions are expected from April 2006, according to the National Health Insurance Fund (OEP).

Under the terms of an agreement with the government, pharmaceutical manufacturers cannot increase the price of reimbursed drugs until end 2006 (Marketletters passim). The last real price increase (5% on average) in this category took place in February 2003.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight